ESC Heart Failure

Article	Citations
Use of Sodium Glucose Co-Transporter 2 Inhibitors in Acute Heart Failure: A Practical Guidance	162
Global Differences in Acute Heart Failure Treatment: Analysis of the STRONG-HF Site Feasibility Questionnaire	101
Serum Angiotensin-Converting Enzyme Levels Indicating Early Sarcoidosis Diagnosis and Immunosuppressive Therapy Efficacy	99
Health-Related Quality of Life Among Transthyretin Amyloid Cardiomyopathy Patients	75
Establishing a Novel Model to Assess Exercise Capacity in Chronic Heart Failure Based on Stress Echocardiography	75
	57
Explainable Machine Learning and Online Calculators to Predict Heart Failure Mortality in Intensive Care Units	57
	56
Analysis of the Serum Levels of RIP3 and Drp1 in Patients with Heart Failure	54
Editors’ Highlight Picks from 2023 in ESC Heart Failure	52
Outcomes with Sacubitril/Valsartan in Outpatients with Heart Failure and Reduced Ejection Fraction: The ARIADNE Registry	52
Oral Milrinone for Management of Refractory Right Ventricular Failure in Patients with Left Ventricular Assist Devices	50
Reductions in Renin-Angiotensin System Inhibitors Following Hospitalization for Heart Failure	50
Effect of SGLT2 inhibitors on hemoglobin and hematocrit levels in Heart failure: a systematic review and meta-analysis	46
New insight: Particle Flow Rate from the Airways as an Indicator of Cardiac Failure in the Intensive Care Unit	45
Impact of Age on Characteristics, Performance Measures and Outcomes of Inpatients for Heart Failure in Beijing, China	45
Integrated Care for Older Multimorbid Heart Failure Patients: Protocol for the ESCAPE Randomized Trial and Cohort Study	45
Issue Information	44
Blood Perfusion Status is Important in the Prognosis of Ventricular Aneurysm Complicated by Ventricular Septal Rupture	44
Use of Liver Stiffness Measurements in Acute Decompensated Heart Failure: New Applications of a Non-Invasive Technique	43
Oral Iron Supplementation in Patients with Heart Failure: A Systematic Review and Meta-Analysis	43
Acylation-Stimulating Protein and Heart Failure Progression in Arrhythmogenic Right Ventricular Cardiomyopathy	43
Uncovering the Genetic Links of SARS-CoV-2 Infections on Heart Failure Co-Morbidity by a Systems Biology Approach	42
The Use of MitraClip for Nonobstructive Hypertrophic Cardiomyopathy with Mixed Severe Mitral Valve Regurgitation	42
Predictive Value of Global Longitudinal Strain by Left Ventricular Ejection Fraction	40

Right Ventricular Strain Predicts Outcome in Patients Receiving Sacubitril/Valsartan: A Sub-Analysis of DISCOVER-ARNI	40
Systemic Immune-Inflammation Index as a Prognostic Marker for Advanced Chronic Heart Failure with Renal Dysfunction	37
Prognostic Value of Left Atrial Strain in Acute and Chronic Heart Failure: A Meta-Analysis	37
Transcatheter Aortic Valve Replacement in Aortic Stenosis and Cardiac Amyloidosis: A Systematic Review and Meta-Analysis	36
Meta-Analysis of Cardiac Magnetic Resonance in Prognosticating Left Ventricular Function in Peripartum Cardiomyopathy	36
Fibroblast Growth Factor 23 Independently Predicts Adverse Outcomes After an Acute Coronary Syndrome	36
Long-Term Outcomes of Electrical Storm Patients Listed for Urgent Heart Transplantation but not Transplanted Acutely	35
Meta-Analysis Global Group in Chronic Heart Failure Score for the Prediction of Mortality in Valvular Heart Disease	35
Real-Time Pulmonary Artery Pressure Monitoring in Heart Failure Patients: An Updated Cost-Effectiveness Analysis	35
Prognostic Value of Hypoxaemic Burden from Overnight Oximetry in Heart Failure with Preserved Ejection Fraction	34
Cardiovascular risk associated with polypharmacy in heart failure: a systematic review and meta-analysis	34
Heart Failure and Trimethylamine N-Oxide: Time to Transform a ‘Gut Feeling’ in a Fact?	34
The adjusted ferritin inflammation index: a novel metric for predicting mortality in heart failure with reduced and mildly reduced ejection fraction	34
Clinical Course of Patients with Hypertrophic Cardiomyopathy Away from Tertiary Referral Care	34
Glucagon-like peptide-1 receptor agonists for prevention of heart failure events in type 2 diabetes and/or obesity	34
Atrial Fibrillation Ablation in Patients with Arrhythmia-Induced Cardiomyopathy: A Prospective Multicentre Study	32
Impact of Early Intensive GDMT on LVEF Recovery and ICD Decision Making in de Novo HFrEF	32
Percutaneous Endocardial Alginate–Hydrogel Injection in the Treatment of Heart Failure: First-in-Human Study	32
Cardiogenic Shock Requiring VA-ECMO Therapy in Scorpionism-Induced Myocarditis	32
Risk Classification for Long-Term Mortality Among Patients with Acute Heart Failure: China PEACE 4YMortality	31
Predictors of stroke volume improvement with AV-optimized conduction system pacing in patients with AV dromotropathy	31
Increased Acylcarnitines in Infant Heart Failure Indicate Fatty Acid Oxidation Inhibition: Towards Therapeutic Options?	31
Calcium Channel Blockers and Clinical Outcomes in Patients with Continuous-Flow Left Ventricular Assist Devices	30
Elevated Activin-A serum levels in patients with acute peripartum cardiomyopathy and during left ventricular recovery	30
Assessing the Link of Malnutrition with Diabetes and Mortality Risk in Heart Failure Patients	30
Arterio-venous gradient of active interleukin-18 is associated with diastolic dysfunction: a cross-sectional study	30
Predicting Cardiovascular Events with Fluoropyrimidine Chemotherapy Using a Standard Cardiovascular Risk Calculator	29
Characteristics and Management of Very Elderly Patients with Heart Failure: A Retrospective, Population Cohort Study	28
Vasopressin in cardiogenic shock: pathophysiology, clinical evidence, and therapeutic perspectives	28
Intense Optimization of Oral Therapy Rapidly Restores Respiratory Function in Worsening Heart Failure Patients	28
Effect of Beta-Blockade on Mortality in Patients with Cardiac Amyloidosis: A Systematic Review and Meta-Analysis	28
Prevalence of Transthyretin Amyloidosis Among Heart Failure Patients with Preserved Ejection Fraction in Japan	28
Trimetazidine in Heart Failure with Preserved Ejection Fraction: A Randomized Controlled Cross-Over Trial	27
Sex Differences in the Impact of Frailty on Patients with Heart Failure: A Retrospective Cohort Study	27
The possible impact of levosimendan infusions on clinical course of heart failure: the results of the LEIA-HF study	27
Early Achievement of Walkability After Cardiac Surgery and the Risk of Cardiovascular Disease After Hospital Discharge	27
Biomarker Profiles in Heart Failure with Preserved vs. Reduced Ejection Fraction: Results from the DIAST-CHF Study	27
Validation of Heart Failure Algorithm for Diagnosing Heart Failure with Preserved Ejection Fraction: A Meta-Analysis	26
Bridging the post-hospitalization gap: a feasibility study of home-based rehabilitation in decompensated heart failure	26
Association of BMI with Adherence and Outcome in Heart Failure Patients Treated with Wearable Cardioverter Defibrillator	26
Angiographic Classification of Total Occlusion and Its Implication on Balloon Pulmonary Angioplasty	25
Human Epididymis Protein 4 is a Useful Predictor of Post-Operative Prognosis in Patients with Severe Aortic Stenosis	25
Letter to the Editor Regarding ‘Autopsy Findings in Cases of Fatal COVID-19 Vaccine-Induced Myocarditis’	24
Platelet Count in Heart Failure Patients Undergoing Left Ventricular Assist Device	24
Effects of Homoarginine Supplementation on Heart and Skeletal Muscle of Rats with Heart Failure with Preserved Ejection Fraction	24
Achieved Dose and Treatment Discontinuation of Candesartan in Men and Women with Chronic Heart Failure: Data from CHARM	24
Prognostic Value of Left Atrial Reverse Remodelling in Patients Hospitalized with Acute Decompensated Heart Failure	24
Advances in Device-Based Treatment of Heart Failure with Preserved Ejection Fraction: Evidence from Clinical Trials	24
Issue Information	24
Long-Term Mortality in Heart Failure with Mid-Range Ejection Fraction: Systematic Review and Meta-Analysis	24

SARS-CoV-2-Related Multisystem Inflammatory Syndrome in Adult Complicated by Myocarditis and Cardiogenic Shock	23
Prognostic Value of Growth Differentiation Factors 15 in Acute Heart Failure Patients with Preserved Ejection Fraction	23
Gender-Specific Prevalence and Trend of Heart Failure in China from 1990 to 2019	23
Lean ZSF1 Rats in Basic Research on Heart Failure with Preserved Ejection Fraction	23
Adrenomedullin Peptides and Precursor Levels in Relation to Haemodynamics and Prognosis After Heart Transplantation	23
Vericiguat and NT-proBNP in Patients with Heart Failure with Reduced Ejection Fraction: Analyses from the VICTORIA Trial	23
Identification of Molecular Signatures in Epicardial Adipose Tissue in Heart Failure with Preserved Ejection Fraction	22
Sex-Specific Associations of Cardiorespiratory Fitness and Galectin-3 in the General Population	22
Time-Domain Heart Rate Variability Features for Automatic Congestive Heart Failure Prediction	22
Importance of Non-Cardiovascular Comorbidities in Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction	22
Effects of Exercise Modalities on Physical Function and Quality of Life in Patients with Heart Failure: A Systematic Review and Network Meta-Analysis	22
Differences Between Cardiogenic Shock Related to Acute Decompensated Heart Failure and Acute Myocardial Infarction	22
Higher BNP/NT-Pro BNP Levels Stratify Prognosis Equally Well in Patients with and Without Heart Failure: A Meta-Analysis	22
Cost-Utility Analysis of Add-On Qili Qiangxin Capsules in Chronic Heart Failure with Reduced Ejection Fraction in China	21
Independent external validation of the LIFE-HF clinical prediction model using the GUIDE-IT trial	21
Takotsubo Cardiomyopathy During Armed Conflict: A Case Series	21
Simultaneous Vaccination Against Influenza and Respiratory Syncytial Virus in High-Risk Heart Failure Patients	21
Regional Expert Opinion: Management of Heart Failure with Preserved Ejection Fraction in the Middle East, North Africa and Turkey	21
Value of right heart haemodynamics for risk stratification of patients with pulmonary arterial hypertension at follow-up	21
Acute Myocarditis According to Age: Presentation, Management and Early Outcomes	21
Incident Heart Failure: Comparing Management and Outcome in Primary and Hospital Settings in Western Sweden 2008–2017	21
Transthyretin Amyloid Cardiomyopathy in Aortic Stenosis Patients Scheduled for Transcatheter Aortic Valve Implantation	21
Congestion, Decongestion, Renal Function and Diuretics in (ESC) Heart Failure	21
Delay in Cardiology Consultation After Primary Care Physician Referrals in Heart Failure: Clinical Implications	21
Clinical Impact of Follow-Up Endomyocardial Biopsy in Myocarditis During or After Immune-Suppressive Therapy	21
A Prospective Analysis of Management and Outcomes of Worsening Heart Failure in the Outpatient Setting	20
Proteins Associated with Rehospitalization, Mortality and Diuretic Resistance in Acutely Decompensated Heart Failure	20
Considerations for Drug Trials in Hypertrophic Cardiomyopathy	20
Left Ventricular Reverse Remodelling as a Promising Strategy for Resolving Left Ventricular Thrombus	20
Rationale and Design of the Biventricular Evaluation of Gliflozins Effects In chroNic Heart Failure: BEGIN-HF Study	20
Dapagliflozin Reduces Pulmonary Vascular Damage and Susceptibility to Atrial Fibrillation in Right Heart Disease	20
Digital Health in Older Adults for the Prevention and Management of Cardiovascular Diseases and Frailty. A Clinical Consensus Statement from the ESC Council for Cardiology Pract	20
Correction to “Understanding the Variability in Red Cell and Plasma Volume Combinations Can Help Guide Management in Heart Failure”	20
Letter to the Editor: Soluble Urokinase Plasminogen Activator Receptor and Outcomes in HFpEF: A TOPCAT Ancillary Study	20
Adaptive Versus Maladaptive Right Ventricular Remodelling	20
Iron deficiency and iron supplementation in heart failure: a dynamic phenotype and a moving therapeutic target	19
Diet–Gut Microbiota Interaction Index and Heart Failure Risk in Diabetes and Prediabetes: Evidence from NHANES 2007–2018	19
Smartwatches in the Assessment of Heart Failure Patients in Epidemiology and Pathophysiology Studies: A Scoping Review	19
Prognostic Impact of Heart Failure Admission in Survivors of Acute Myocardial Infarction	19
Body Mass Index, Frailty, and Outcomes in Heart Failure with Preserved Ejection Fraction	19
Long-Term Prognosis of Pure and Impure Tachycardiomyopathy	19
Plasma Volume Status Predicting Clinical Outcomes in Patients Undergoing Transcatheter Edge-To-Edge Mitral Valve Repair	19
Role of Vericiguat in Management of Patients with Heart Failure with Reduced Ejection Fraction After Worsening Episode	19
Sex-Based Differences in Referral of Heart Failure Patients to Outpatient Clinics: A Scoping Review	19
Novel Mutation Associated with Non-Compaction Ventricular Myocardium: A Case Report	19
Early Diagnosis, Disease Stage and Prognosis in Wild-Type Transthyretin Amyloid Cardiomyopathy: The DIAMOND Study	19
Pre-Emptive Treatment of Heart Failure Exacerbations in Patients Managed with the HeartLogic™ Algorithm	19
Clinical Application and Immune Infiltration Landscape of Stemness-Related Genes in Heart Failure	18
Dose Titration of Sacubitril/Valsartan for Heart Failure with Reduced Ejection Fraction: A Real-World Study	18
Cognitive Transitions Based on Functional Status in Older Adults with Heart Failure: A Population-Based Study	18
A Meta-Analysis of the Relationship Between Glycaemic Variability and the Mortality of Patients with Heart Failure	18
A Polygenic Risk Score of Atrial Fibrillation Improves Prediction of Lifetime Risk for Heart Failure	18
Impact of Cardiac Resynchronization Therapy Optimization Inside a Heart Failure Programme: A Real-World Experience	18
Predicted Impact of Atrial Flow Regulator on Survival in Heart Failure with Reduced and Preserved Ejection Fraction	18
Corrigendum	18
Real-World Effectiveness of Targeted Therapies in ATTR Cardiomyopathy: A Meta-Analysis Integrating Population-Based Data	18
Letter Regarding the Article “Hypocapnia is an Independent Predictor of In-Hospital Mortality in Acute Heart Failure”	18
Temporal Profiling of M-TEER-Related Complications	18
Narrative Synthesis of the Effectiveness and Characteristics of Heart Failure Disease Self-Management Support Programmes	18
Novel Electrocardiographic Criteria May Render Possible the More Accurate Recognition of Cardiac Amyloidosis	18
Incidence, Mortality, and Predictors of Acute Kidney Injury in Patients with Heart Failure: A Systematic Review	17
Genotype is Associated with Left Ventricular Reverse Remodelling and Early Events in Recent-Onset Dilated Cardiomyopathy	17
Comparative Analysis of Randomized versus Real World Populations in Heart Failure: DIAMOND Trial versus CARE-HK Registry	17
The Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in Patients Aged Over 80 Years with Heart Failure	17
The Characteristic Large-Scale Annual Analysis by Gender and Age in Heart Failure Patients: Cohort for 10 Years in Korea	17
Changes Over Time in Patient-Reported Outcomes in Patients with Heart Failure	17
Cardiovascular vs. Non-Cardiovascular Deaths After Heart Failure Hospitalization in Young, Older, and Very Old Patients	17
Comments on ‘The cardio–pancreatic axis in heart failure: from conceptual framework to empirical evidence’	17
Baroreflex Activation Therapy in Patients with Heart Failure with Reduced Ejection Fraction: A Single-Centre Experience	17
Diagnostic and Prognostic Value of the Left Atrial Myopathy Evaluation in Cardiac Amyloidosis Using Echocardiography	17
Letter to Dr Maria Giulia Bellicini, MD, Brescia, in response to her letter to the editor of our published paper in ESC Heart Failure (online); Worse long-term outcomes in new-onset HFpEF vs HFrEF and	17
Analysis of the Usefulness and Benefits of Ultrafiltration in Cardiorenal Syndrome: A Systematic Review	17
Investigating the Relationship Between Frailty and Quality of Life in Patients with Heart Failure and CKD (FRAIL Study)	17
A Contemporary Simple Risk Score for Prediction of Severe Acute Kidney Injury After Heart Transplantation	17
Efficacy and Safety of Digital Therapeutics-Based Cardiac Rehabilitation in Heart Failure Patients: A Systematic Review	17
E Prostanoid Receptor-3 Promotes Oxidized Low-Density Lipoprotein-Induced Human Aortic Smooth Muscle Cells Inflammation	17
The Impact of Heart Failure Therapy in Patients with Mildly Reduced Ejection Fraction: A Network Meta-Analysis	17
Interplay Between Acute Heart Failure and COPD in Patients Hospitalized for Dyspnea: Prognostic Insights From the PARADISE Cohort	17
Tyrosine to Threonine Ratio was Related to Heart Failure with Reduced or Mildly Reduced Ejection Fraction	17
Severe Aortic Insufficiency-Induced Cardiogenic Shock Treated with Left Atrial VA-ECMO and Emergent Valve-in-Valve TAVR	17

Biomarker Prognostication Across Universal Definition of Heart Failure Stages	17
Biomarkers in Heart Failure: Traditional and Emerging Indicators for Prognosis	17
Effects of Door-to-Tolvaptan Time on Short-Term Clinical Outcome in Patients with Acute Heart Failure	17
Clinical Performance and Quality Measures for Heart Failure Management in China: The China-Heart Failure Registry Study	17
Safety and Efficacy of MitraClip in Acutely Ill (NYHA Class IV) Patients with Mitral Regurgitation: Results from the Global EXPAND Study	16
Integrin Beta-Like 1 is Regulated by DNA Methylation and Increased in Heart Failure Patients	16
S2I2N0–3 Score Predicts Short- and Long-Term Mortality and Morbidity in HFrEF: A Post-Hoc Analysis of the GUIDE-IT Trial	16
Life-saving Balloon Aortic Valvuloplasty performed in a patient with cardiogenic shock	16
Global burden of heart failure due to cardiovascular diseases, 1990–2021 and predictions to 2035 based on GBD 2021	16
Interpretation of Elevated Baseline Concentrations and Serial Changes of High-Sensitivity Cardiac Troponin T in Confirmed Muscular Dystrophies	16
Systematic Review of Sodium-Glucose Cotransporter 2 Inhibitors: A Hopeful Prospect in Tackling Heart Failure-Related Events	16
IgM-Enriched Immunoglobulin as Adjuvant Therapy for Heart Transplant After Infection of Left Ventricular Assist Devices	16
Paediatric Heart Transplantation During the COVID-19 Pandemic in Iran: Single-Centre Experience	16
Eniluracil Blocks AREG Signalling-Induced Pro-Inflammatory Fibroblasts of Melanoma in Heart Failure	16
The prognostic value of RV strain in patients with heart failure with reduced ejection fraction on sacubitril/valsartan: a critical appraisal and future directions	16
Comprehensive Exploration of Unexplained Dyspnoea in Subjects with Normal Ejection Fraction and Low Natriuretic Peptides	16
Issue Information	16
Mavacamten in Real-Life Practice: Initial Experience at a Hypertrophic Cardiomyopathy Centre	16
Utilizing Longitudinal Data in Assessing All-Cause Mortality in Patients Hospitalized with Heart Failure	16
Correction to: “Obesity and Contraceptive Use: Impact on Cardiovascular Risk”	16
Issue Information	16
Relationship Between Haemodynamic Indicators and Haemogram in Patients with Heart Failure	16
Is Ischaemic Heart Failure an Autoimmune Disease?	16
Baseline Kidney Function and the Effects of Dapagliflozin On Health Status in Heart Failure in DEFINE-HF and PRESERVED-HF	16
Sodium-Glucose Transporter 2 Inhibitors May Improve the Prognosis of Acute Heart Failure by Correcting Hypocapnia	16
Alcohol Septal Ablation in Hypertrophic Cardiomyopathy: For Which Patients?	16
Therapy Gaps for Patients with Heart Failure and Reduced Kidney Function: A Prospective Cohort Study	15
Trametinib Alters Contractility of Paediatric Noonan Syndrome-Associated Hypertrophic Myocardial Tissue Slices	15
Real-world data on early initiation of sodium-glucose co-transporter-2 inhibitors in newly diagnosed heart failure with reduced ejection fraction	15
Atrial-Secondary Tricuspid Regurgitation: A Better Prognosis in Early Stage Heart Failure, But Not in Late Stage	15
Hyperkalaemia as a Cause of Undertreatment with Mineralocorticoid Receptor Antagonists in Heart Failure	15
Prognostic Implications of Functional Tricuspid Regurgitation in Asymptomatic Degenerative Mitral Regurgitation	15
Diuretic Dose is a Strong Prognostic Factor in Ambulatory Patients Awaiting Heart Transplantation	15
Multiorgan Characterization of Inflammasome Component Expression in a Rat Model of Advanced Heart Failure	15
Non-Dilated Left Ventricular Cardiomyopathy vs. Dilated Cardiomyopathy: Clinical Background and Outcomes	15
Effects of Bariatric Surgery on Cardiovascular-Related Acute Care Use in Patients with Hypertrophic Cardiomyopathy	15
Low-Density Lipoprotein Cholesterol, Erythrocyte, and Platelet in Heart Failure with Preserved Ejection Fraction	15
Fractional Excretion of Urea Nitrogen Can Identify True Worsening Renal Function in Patients with Heart Failure	15
Estimated Pulse Wave Velocity and Risk of New-Onset Heart Failure	15
A Nationwide Study of Temporal Trends of Cause-Specific Hospital Readmissions in Patients with Heart Failure	15
Acetazolamide effects on natriuresis and diuresis in acute heart failure treated with furosemide and SGLT2i (SANDI)	15
ST-Segment Depression and Left Ventricular Systolic Function Recovery Post-Atrial Fibrillation Ablation in Heart Failure	14
Sex-Related Pathophysiological Mechanisms May Be Present Before Symptoms of HFpEF Develop	14
Decreased Endogenous Nitric Oxide Production in Acute Decompensated Heart Failure with a Reduced Ejection Fraction	14
Clinical Characteristics, Outcome, and Therapeutic Effect of Tafamidis in Wild-Type Transthyretin Amyloid Cardiomyopathy	14
Improved Mortality and Haemodynamics with Milrinone in Cardiogenic Shock Due to Acute Decompensated Heart Failure	14
Vericiguat Improves Cardiac Remodelling and Function in Rats with Doxorubicin-Induced Cardiomyopathy	14
Myocardial testosterone glucuronide and disease phenotypes in hypertrophic cardiomyopathy	14
Long Term Changes in Health-Related Quality of Life for People with Heart Failure: The ECHOES Study	14
Associations Between In-Hospital Daily Protein Intake and Adverse Clinical Outcomes in Older Patients with Heart Failure	14
U-Shaped Association Between Body Mass Index and Ejection Fraction in Intensive Care Unit Patients with Heart Failure	14
Ten Year Age- and Sex-Specific Temporal Trends in Incidence and Prevalence of Heart Failure in Västra Götaland, Sweden	14
Multidisciplinary Care: A Missing Solution to SGLT2 Inhibitor Underuse in Heart Failure	14
Predicting 1-Year Heart Failure Hospitalization and Mortality Post-Discharge from the Intensive Cardiac Care Unit	14
Use of soluble guanylyl cyclase stimulators in heart failure therapy—a mode of action perspective	14
Relationship of Atrial Fibrillation and N Terminal Pro Brain Natriuretic Peptide in Heart Failure Patients	14
Serum a-1 Antitrypsin as a Novel Biomarker in Chronic Heart Failure	14
Association between cumulative exposure to cardiometabolic index and risk of heart failure: a prospective cohort study	14
Prognostic Value of High-Sensitivity Cardiac Troponin I in Patients with Non-Ischaemic Heart Failure: Insights from China	14
A Case of Biopsy-Proven Inflammatory Dilated Cardiomyopathy Following Heterologous mRNA-1273 Third-Dose Immunization	14
Prognostic Impact of Beta-Blocker Use by N-Terminal Pro-Brain Natriuretic Peptide Level in Acute Heart Failure Patients	14
Association of Hypoxic Burden Metrics with Cardiovascular Outcomes in Heart Failure and Sleep-Disordered Breathing	14
Impact of the COVID-19 Pandemic on Management and Outcomes of Patients with Acute Heart Failure	14
A Pilot Study on DNA Methylation Changes for Non-Invasive Molecular Diagnostics in Heart Failure	14
Metformin inhibits proliferation of residing fibroadipogenic progenitor cells from failing human hearts	14
Prognosis of tricuspid regurgitation after mitral transcatheter edge-to-edge repair: the EXPANDed studies	14
Clinical Profile and 90 Day Outcomes of 10 851 Heart Failure Patients Across India: National Heart Failure Registry	14
Decoding Cardiogenic Shock: Assessing Shock Index and Its Variants as Prognostic Indicators for In-Hospital Mortality	14
Cardiac Arrest Caused by Coronary Occlusion During Transcatheter Aortic Valve Implantation: A Unique Cause	14
Initial Experience with Transcatheter Tricuspid Valve Repair in Patients with Cardiac Amyloidosis	14
Transition from Asymptomatic to Symptomatic Systolic Chronic Heart Failure: Rationale and Design of TransitionCHF	14
Correction to “Impact Analysis of Heart Failure Across European Countries: An ESC-HFA Position Paper” and “Echocardiographically Defined Haemodynamic Categorization Predicts Prognosis in Ambulatory He	14
Immune Checkpoint Inhibitors and Cardiovascular Adverse Events	13
Clinical Impacts of Sacubitril/Valsartan on Patients Eligible for Cardiac Resynchronization Therapy	13
Electrical Cardioversion of Atrial Arrhythmias with Cardiac Amyloidosis in the Era of Direct Oral Anticogulants	13
Risk Prediction of Mortality for Patients with Heart Failure in England: Observational Study in Primary Care	13
Sphingosine-1-Phosphate Improves Outcome of No-Reflow Acute Myocardial Infarction Via Sphingosine-1-Phosphate Receptor 1	13
Re-PERFUSE: Phase 1b Study of AZD3427, a Novel Relaxin Receptor Agonist, on Renal Perfusion in HFrEF Patients	13
Sarcopenia Prognosis Using Dual-Energy X-Ray Absorptiometry and Prediction Model in Older Patients with Heart Failure	13
A Case for Intranasal Bumetanide for the Management of Heart Failure	13
Prognostic Impact of Plasma Volume Status During Hospital Admission in Patients with Acute Decompensated Heart Failure	13
Neutrophil-to-Lymphocyte Ratio: Link to Congestion, Inflammation, and Mortality in Outpatients with Heart Failure	13
Outpatient Treatment of Decompensated Heart Failure: A Systematic Review and Study Level Meta-Analysis	13
Spontaneous Coronary Hematoma Concomitant with Myocarditis: The First Report of Double Cardiac Complication of Dengue	13
A Year in Heart Failure: Updates of Clinical and Preclinical Findings	13
Issue Information	13
The Intelligent Impella: Future Perspectives of Artificial Intelligence in the Setting of Impella Support	13
Pre-Admission Beta-Blocker Therapy and Outcomes in Cardiogenic Shock: Insights from the Altshock-2 Registry	13
Increased Calcification by Erythrophagocytosis in Aortic Valvular Interstitial Cells	13
Bridging the gap in heart failure management: the effect of a cross-disciplinary intervention on guidelines-directed medical therapy in primary care	13
Assessing the Diversity and Determinants of Health-Related Quality of Life Measures in Patients with Acute Heart Failure	13
Aortic Thoracic Neuromodulation in Heart Failure with Preserved Ejection Fraction	13
Transjugular Tricuspid Valve-in-Ring Replacement Using the Novel System Under Three-Dimensional Printing Guidance	13
Apixaban in Bridge to Transplant and Destination LVAD - Rationale and Study Design: The ApixiVAD Trial	13
Established and emerging pharmacologic options and unmet needs in HFpEF and HFmrEF	13